156 related articles for article (PubMed ID: 11305151)
41. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease.
El-Serag HB; Johanson JF
Scand J Gastroenterol; 2002 Aug; 37(8):899-904. PubMed ID: 12229963
[TBL] [Abstract][Full Text] [Related]
42. Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group.
Voutilainen M; Färkkilä M; Mecklin JP; Juhola M; Sipponen P
Am J Gastroenterol; 1999 Nov; 94(11):3175-80. PubMed ID: 10566710
[TBL] [Abstract][Full Text] [Related]
43. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
[TBL] [Abstract][Full Text] [Related]
44. Features of gastroesophageal reflux disease in women.
Lin M; Gerson LB; Lascar R; Davila M; Triadafilopoulos G
Am J Gastroenterol; 2004 Aug; 99(8):1442-7. PubMed ID: 15307857
[TBL] [Abstract][Full Text] [Related]
45. [Analysis of the grade of esophagitis, chromendoscopical and histological findings of esophagus in patients with gastroesophageal reflux disease before and after the therapy].
Brzacki V; Nagorni A; Mihailović D; Raicević-Sibinović S; Mladenović B
Vojnosanit Pregl; 2010 Dec; 67(12):991-7. PubMed ID: 21425557
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of esophagitis in patients with pH-documented laryngopharyngeal reflux.
Koufman JA; Belafsky PC; Bach KK; Daniel E; Postma GN
Laryngoscope; 2002 Sep; 112(9):1606-9. PubMed ID: 12352672
[TBL] [Abstract][Full Text] [Related]
47. [Surgery of reflux esophagitis--a renaissance].
Strobel O; Uhl W; Scholz T; Büchler MW
Ther Umsch; 2001 Mar; 58(3):151-7. PubMed ID: 11305153
[TBL] [Abstract][Full Text] [Related]
48. Gastroesophageal Reflux Disease.
Kellerman R; Kintanar T
Prim Care; 2017 Dec; 44(4):561-573. PubMed ID: 29132520
[TBL] [Abstract][Full Text] [Related]
49. Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal diseases in China (SILC).
Zou D; He J; Ma X; Chen J; Gong Y; Man X; Gao L; Wang R; Zhao Y; Yan X; Liu W; Wernersson B; Johansson S; Dent J; Sung JJ; Li Z
Scand J Gastroenterol; 2011 Feb; 46(2):133-41. PubMed ID: 20955088
[TBL] [Abstract][Full Text] [Related]
50. Clinical epidemiology and natural history of gastroesophageal reflux disease.
Sonnenberg A; El-Serag HB
Yale J Biol Med; 1999; 72(2-3):81-92. PubMed ID: 10780569
[TBL] [Abstract][Full Text] [Related]
51. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.
Malfertheiner P; Lind T; Willich S; Vieth M; Jaspersen D; Labenz J; Meyer-Sabellek W; Junghard O; Stolte M
Gut; 2005 Jun; 54(6):746-51. PubMed ID: 15888776
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
[TBL] [Abstract][Full Text] [Related]
53. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
[TBL] [Abstract][Full Text] [Related]
54. Effects of environment and lifestyle on gastroesophageal reflux disease.
Sonnenberg A
Dig Dis; 2011; 29(2):229-34. PubMed ID: 21734389
[TBL] [Abstract][Full Text] [Related]
55. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.
El-Serag HB; Graham DY; Satia JA; Rabeneck L
Am J Gastroenterol; 2005 Jun; 100(6):1243-50. PubMed ID: 15929752
[TBL] [Abstract][Full Text] [Related]
56. Relevance of ineffective esophageal motility and hyperactive acid sensitization in patients with gastroesophageal reflux.
Hong SJ; Ko BM; Jung IS; Ryu CB; Moon JH; Cho JY; Kim JO; Lee JS; Lee MS; Shim CS; Kim BS
J Gastroenterol Hepatol; 2007 Oct; 22(10):1662-5. PubMed ID: 17559356
[TBL] [Abstract][Full Text] [Related]
57. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
Gisbert JP; Pajares JM; Losa C
Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661
[TBL] [Abstract][Full Text] [Related]
58. [Gastroesophageal reflux disease and dyspepsia--drug therapy].
Gräter H
Praxis (Bern 1994); 2006 Aug; 95(31-32):1179-83. PubMed ID: 16909686
[TBL] [Abstract][Full Text] [Related]
59. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status.
Inomata Y; Koike T; Ohara S; Abe Y; Sekine H; Iijima K; Ariizumi K; Yamagishi H; Kitagawa Y; Imatani A; Shimosegawa T
Am J Gastroenterol; 2006 May; 101(5):926-33. PubMed ID: 16573782
[TBL] [Abstract][Full Text] [Related]
60. Gastroesophageal reflux disease: clinical manifestations.
Williams JL
Gastroenterol Nurs; 2003; 26(5):195-200. PubMed ID: 14603078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
